FROM 10-Q

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

January 14, 2021

Period of Report

November 30, 2020

Accession Number

0001104659-21-004303

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →